Lundbeckfond Ventures (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:
Copenhagen
Average round investment:
27.91M USD

Lundbeckfond Ventures is an evergreen life science venture fund investing in life science companies primarily in Europe, up to €50 million annualy.

Lundbeckfonden Ventures aims to support the group's activities and operating independently from the Lundbeckfonden’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

We tracked 10 Nordic investments.

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Lundbeckfond Ventures investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Lundbeckfond Ventures mostly invests with:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to Lundbeckfond Ventures:

InvestorCriteria
Denmark Sunstone Life Science Ventures
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Denmark Novo A/S
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Accel
57%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Denmark Novo Seeds
56%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
France Idinvest Partners
54%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Index Ventures
54%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Sweden PÄAB
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United Kingdom Dawn Capital
50%
  • Range for average deal size: 20M - 50M USD
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2
  • Active last 12 months: Yes
Norway Ferd Capital
49%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Norway Sarsia Seed Management
48%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.7

News about Lundbeckfond Ventures

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)